Literature DB >> 25705035

Prevalence of manual Strauss LBBB criteria in patients diagnosed with the automated Glasgow LBBB criteria.

Jakob Almer1, Robbert Zusterzeel2, David G Strauss2, Elin Trägårdh1, Charles Maynard3, Galen S Wagner4, Henrik Engblom5.   

Abstract

INTRODUCTION: About one-third of patients undergoing cardiac resynchronization therapy because of left bundle branch block (LBBB) and heart failure do not improve. Strauss et al. have developed strict criteria to more accurately define complete LBBB in this patient group. The aim of this study was to investigate the prevalence of the manual application of the Strauss criteria for LBBB (QRS ≥ 140 ms in men, ≥ 130 ms in women, along with mid-QRS notching/slurring) in consecutive patients who have been diagnosed with LBBB by the automated Glasgow criteria (QRS ≥ 120 ms).
METHOD: In 158 consecutive patients (78 females) diagnosed with LBBB according to the automated Glasgow criteria, the manual Strauss criteria were applied. RESULTS &
CONCLUSION: A majority of patients (87%) diagnosed with LBBB using the Glasgow criteria were positive for the Strauss criteria. In 70% (13/20) of the cases of disagreement the reason for disagreement was short QRS duration.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRT; Diagnostic criteria; ECG; LBBB

Mesh:

Year:  2015        PMID: 25705035     DOI: 10.1016/j.jelectrocard.2015.01.008

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

Review 1.  Left bundle branch block and the evolving role of QRS morphology in selection of patients for cardiac resynchronization.

Authors:  Kelley P Anderson
Journal:  J Interv Card Electrophysiol       Date:  2018-08-20       Impact factor: 1.900

2.  Long-term outcome of intraventricular conduction delays in the general population.

Authors:  Jani Rankinen; Petri Haataja; Leo-Pekka Lyytikäinen; Heini Huhtala; Terho Lehtimäki; Mika Kähönen; Markku Eskola; Andrés Ricardo Pérez-Riera; Antti Jula; Harri Rissanen; Kjell Nikus; Jussi Hernesniemi
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-08-17       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.